Base
Proposed RuleSignificant2016-071282016-03-30

Medication Assisted Treatment for Opioid Use Disorders

Health and Human Services Department

Abstract

The Secretary of the Department of Health and Human Services (the Secretary) (HHS) proposes a rule to increase the highest patient limit for qualified physicians to treat opioid use disorder under section 303(g)(2) of the Controlled Substances Act (CSA) from 100 to 200. The purpose of the proposed rule is to increase access to treatment for opioid use disorder while reducing the opportunity for diversion of the medication to unlawful use.

Action & Dates

Action
Proposed rule.
Dates
To be assured consideration, comments must be received at one of the addresses provided below, no later than 5 p.m. on May 31, 2016.

CFR References

Topics

Health professionsMethadoneReporting and recordkeeping requirements

Public Comment

Comments Close
2016-05-31

Document Excerpt

Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Health and Human Services 42 CFR Part 8 RIN 0930-AA22 AGENCY: Substance Abuse and Mental Health Services Administration (SAMHSA), HHS. ACTION: Proposed rule. SUMMARY: The Secretary of the Department of Health and Human Services (the Secretary) (HHS) proposes a rule to increase the highest patient limit for qualified physicians to treat opioid use disorder under section 303(g)(2) of the Controlled Substances Act (CSA) from 100 to 200. The purpose of the proposed rule is to increase access to treatment for opioid use disorder while reducing the opportunity for diversion of the medication to unlawful use. DATES: To be assured consideration, comments must be received at one of the addresses provided below, no later than 5 p.m. on May 31, 2016. ADDRESSES: You may submit comments, identified by Regulatory Information Number (RIN) 0930-AA22, by any of the following methods: Electronically: Federal eRulemaking Portal: Go to http://www.regulations.gov and follow the instructions for submitting comments. Regular Mail or Hand Delivery or Courier: Written comments mailed by regular mail must be sent to the following address only: The Substance Abuse and Mental Health Services Administration, Department of Health and Human Services, Attn: Jinhee Lee, SAMHSA, 5600 Fishers Lane, Room 13E21C, Rockville, Maryland 20857. Please allow sufficient time for mailed comments to be received before the close of the comment period. Express or Overnight Mail: Written comments sent by hand

Read full document on FederalRegister.gov →

Full Document

Citation: 81 FR 17639